wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q51397243-666B4883-7D25-4EA7-BAF8-1425E8007723
Q51397243-666B4883-7D25-4EA7-BAF8-1425E8007723
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51397243-666B4883-7D25-4EA7-BAF8-1425E8007723
Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.
P2860
Q51397243-666B4883-7D25-4EA7-BAF8-1425E8007723
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51397243-666B4883-7D25-4EA7-BAF8-1425E8007723
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1622ee051f96f0ac95ca076f42639f4c7214214b
P2860
Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.